BCC's goal in conducting this study was to determine the current status of the U.S. in vitro toxicity testing market and assess its growth potential over the 5-year period from 2006 to 2011. We were particularly interested in understanding the current market scenario for alternative measures to animal testing. Predictive toxicology is often cross-referenced with in vitro methods. This report assesses the growth and market potential for these methods. In addition, we were interested in understanding the impact of these methods on different industry sectors.
Our key objective was to present a comprehensive analysis of the current in vitro toxicity testing market in the United States and its future direction.
SCOPE OF STUDY
This report contains:
BCC presents an analysis by the different technology approaches and revenue split by different applications for 2006. Then, based on our surveys, we analyze the potential of the technologies that encompass mechanistic and non-mechanistic and forecast revenue projections for 2006 and 2011. We also analyze revenues by the four major industry groups that use toxicology testing.
BCC surveyed numerous companies to obtain data for this study. Included were manufacturers of reagents and test kits for different toxicity testing categories, contract research organizations, testing services for toxicity, and some technology vendors. We also spoke with end users in different industries. In addition, we compiled data from government sources.
ABOUT THE AUTHOR
Vanita Khetan is a healthcare domain analyst and an entrepreneur. She holds a bachelors degree in Chemistry and a postgraduate degree in Management. During the course of her career, she has analyzed U.S., European and Asian markets in biotechnology, pharmaceuticals, medical devices, wound care, and surgical goods. This is her first publication with BCC Research.